These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32498337)

  • 1. Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study.
    Barretto JR; Boa-Sorte N; Vinhaes CL; Malta-Santos H; Rebouças-Silva J; Ramos CF; Torres-Nascimento MAS; Borges VM; Andrade BB
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32498337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Overweight and Obesity on Liver Biochemical Markers in Children and Adolescents.
    Johansen MJ; Gade J; Stender S; Frithioff-Bøjsøe C; Lund MAV; Chabanova E; Thomsen HS; Pedersen O; Fonvig CE; Hansen T; Holm JC
    J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31617910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community-based cross-sectional study.
    Chen LW; Huang MS; Shyu YC; Chien RN
    Kaohsiung J Med Sci; 2021 Sep; 37(9):819-827. PubMed ID: 34002481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].
    Guijarro de Armas MG; Monereo Megías S; Navea Aguilera C; Merino Viveros M; Vega Piñero MB
    Med Clin (Barc); 2015 Jan; 144(2):55-8. PubMed ID: 24768200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between alanine aminotransferase as surrogate of fatty liver disease and physical activity and sedentary time in adolescents with obesity.
    Julian V; Bergsten P; Ennequin G; Forslund A; Ahlstrom H; Ciba I; Dahlbom M; Furthner D; Gomahr J; Kullberg J; Maruszczak K; Morwald K; Olsson R; Pixner T; Schneider A; Pereira B; Ring-Dimitriou S; Thivel D; Weghuber D
    Eur J Pediatr; 2022 Aug; 181(8):3119-3129. PubMed ID: 35771354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between 25-hydroxyvitamin D concentration and liver enzymes in overweight or obese adults: Cross-sectional and interventional outcomes.
    Naderpoor N; Mousa A; de Courten M; Scragg R; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():193-199. PubMed ID: 28899715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical, anthropometric and body composition indicators as predictors of hepatic steatosis in obese adolescents.
    Gobato AO; Vasques AC; Yamada RM; Zambon MP; Barros-Filho Ade A; Hessel G
    Rev Paul Pediatr; 2014 Jun; 32(2):230-6. PubMed ID: 25119755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic steatosis and severity-related factors in obese children.
    Navarro-Jarabo JM; Ubiña-Aznar E; Tapia-Ceballos L; Ortiz-Cuevas C; Pérez-Aísa MA; Rivas-Ruiz F; Andrade RJ; Perea-Milla E
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1532-8. PubMed ID: 23701491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
    Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F
    Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Ferritin Correlates With Liver Fat in Male Adolescents With Obesity.
    Mörwald K; Aigner E; Bergsten P; Brunner SM; Forslund A; Kullberg J; Ahlström H; Manell H; Roomp K; Schütz S; Zsoldos F; Renner W; Furthner D; Maruszczak K; Zandanell S; Weghuber D; Mangge H
    Front Endocrinol (Lausanne); 2020; 11():340. PubMed ID: 32625166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.
    Draijer LG; Feddouli S; Bohte AE; Vd Baan Slootweg O; Pels Rijcken TH; Benninga MA; Stoker J; Koot BGP
    Eur J Pediatr; 2019 Jun; 178(6):863-870. PubMed ID: 30903305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinically relevant method to screen for hepatic steatosis in overweight adolescents: a cross sectional study.
    Saad V; Wicklow B; Wittmeier K; Hay J; MacIntosh A; Venugopal N; Ryner L; Berard L; McGavock J
    BMC Pediatr; 2015 Oct; 15():151. PubMed ID: 26450572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome, hepatic steatosis, and cardiovascular risk in children.
    Rutigliano I; Vinci R; De Filippo G; Mancini M; Stoppino L; d'Apolito M; Giardino I; Macarini L; Pettoello Mantovani M; Campanozzi A
    Nutrition; 2017 Apr; 36():1-7. PubMed ID: 28336101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and risk factors for hepatic steatosis in Northern Italy.
    Bellentani S; Saccoccio G; Masutti F; Crocè LS; Brandi G; Sasso F; Cristanini G; Tiribelli C
    Ann Intern Med; 2000 Jan; 132(2):112-7. PubMed ID: 10644271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis.
    Long MT; Pedley A; Colantonio LD; Massaro JM; Hoffmann U; Muntner P; Fox CS
    Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1172-1180.e2. PubMed ID: 27046482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome.
    Banderas DZ; Escobedo J; Gonzalez E; Liceaga MG; Ramírez JC; Castro MG
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):805-10. PubMed ID: 22546752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test.
    Guzzaloni G; Grugni G; Minocci A; Moro D; Morabito F
    Int J Obes Relat Metab Disord; 2000 Jun; 24(6):772-6. PubMed ID: 10878685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M30 does not predict the severity of hepatosteatosis, whereas adiponectin level declined with increase of ALT and the severity of hepatic steatosis.
    Caner S; Altınbaş A; Saykı M; Büyükcam F; Yılmaz B; Çakal E; Çoban Ş; Delibaşı T
    J Clin Lab Anal; 2014 Sep; 28(5):381-5. PubMed ID: 24648300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.